TrialThe Lancet. Oncology2014

Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial.

Sung Won Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.